A GATA4-regulated tumor suppressor network represses formation of malignant human astrocytomas
Open accessThe DOI matches its Crossref record; 51 of the 53 references it cites were found in a registry or an index.
Abstract
Glioblastoma Multiforme (GBM), the most common and lethal primary human brain tumor, exhibits multiple molecular aberrations. We report that loss of the transcription factor GATA4, a negative regulator of normal astrocyte proliferation, is a driver in glioma formation and fulfills the hallmarks of a tumor suppressor gene (TSG). Although GATA4 was expressed in normal brain, loss of GATA4 was observed in 94/163 GBM operative samples and was a negative survival prognostic marker. GATA4 loss occurred through promoter hypermethylation or novel somatic mutations. Loss of GATA4 in normal human astrocytes promoted high-grade astrocytoma formation, in cooperation with other relevant genetic alterations such as activated Ras or loss of TP53. Loss of GATA4 with activated Ras in normal astrocytes promoted a progenitor-like phenotype, formation of neurospheres, and the ability to differentiate into astrocytes, neurons, and oligodendrocytes. Re-expression of GATA4 in human GBM cell lines, primary cultures, and brain tumor–initiating cells suppressed tumor growth in vitro and in vivo through direct activation of the cell cycle inhibitor P21CIP1, independent of TP53. Re-expression of GATA4 also conferred sensitivity of GBM cells to temozolomide, a DNA alkylating agent currently used in GBM therapy. This sensitivity was independent of MGMT (O-6-methylguanine-DNA-methyltransferase), the DNA repair enzyme which is often implicated in temozolomide resistance. Instead, GATA4 reduced expression of APNG (alkylpurine-DNA-N-glycosylase), a DNA repair enzyme which is poorly characterized in GBM-mediated temozolomide resistance. Identification and validation of GATA4 as a TSG and its downstream targets in GBM may yield promising novel therapeutic strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4. Re-expression of GATA4 suppresses cell proliferation and in vivo tumor growth. (A) Transient expression of GATA4 under a constitutive active CMV promoter or empty vector control (EV) decreases proliferation in several GBM cell lines of varying genetic backgrounds. *, P < 0.01 (B) Transient expression of GATA4 leads to attenuation of cyclin D1 with increased levels of P21CIP1 and P15INK4B. (C and D) Doxycycline was added to U87 GBM cell line expressing GATA4 under a doxycycline-inducible promoter. (C) At indicated time points, GATA4, P21CIP1, and CCND1 were measured by Western blotting. (D) At the indicated times, cells in culture were counted. *, P = 0.001. (E) Survival curve of NOD-SCID mice were injected with intracranial xenografts of U87 cells with GATA4 under doxycycline (DOX)-inducible promoter. Mice were continually given doxycycline in drinking water (GATA4 on, n = 10) or no doxycycline (GATA4 off, n = 10). (F) Immunohistochemical analysis of protein markers from tumors of mice not given dox (no GATA4) versus mice given dox (GATA4). Bars: (first H&E column) 500 µm; (second [magnified] H&E column) 50 µm; (GATA4, P21-CIP1, and ki67 columns) 25 µm. (G) Quantification of protein staining from F. n = 5 mice. *, P < 0.01. Mean and SEM are shown. A and D were performed in triplicate with mean and SEM reported.](https://figures.cochat.ai/paper-figures/e27f9fa4163d45d392526cacac7e15a2/a-gata4-regulated-tumor-suppressor-network-represses-formation-of-malignant-figure-4.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“GATA4 is frequently silenced in lung, colon, prostate, ovarian, and breast cancer (38, 39).”
From The DNA damage response induces inflammation and senescence by inhibiting autophagy of GATA4. (2015) · cites this paper as [39]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
The 2007 WHO Classification of Tumours of the Central Nervous System
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0243-4 · Cited by 15,397 · cited 1×
“GBMs have been categorized into either primary or secondary subtypes (Louis et al., 2007).”
BackgroundComprehensive genomic characterization defines human glioblastoma genes and core pathways
The Cancer Genome Atlas Research Network (2008) · Nature · doi:10.1038/nature07385 · Cited by 7,735
Self-citationVerhaak, R. G. W., Hoadley, K. A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M. D., Miller, C. R., Ding, L., Golub, T., Mesirov, J. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.020 · Cited by 7,575 · cited 2×
“Toward this goal, several approaches have been undertaken, including recent genome-wide sequencing approaches, which have pointed to a large number of novel and known genetic alterations present in GBMs (Cancer Genome Atlas Research Network, 2008; Parsons et al., 2008; Verhaak et al., 2010).”
BackgroundIdentification of human brain tumour initiating cells
Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,433 · cited 1×
“These BTICs are able to selfrenew, proliferate, and give rise to different lineages (Singh et al., 2004; Stiles and Rowitch, 2008).”
BackgroundSelf-citationMGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
Hegi, M. E., Diserens, A.-C., Gorlia, T., Hamou, M.-F., de Tribolet, N., Weller, M., Kros, J. M., Hainfellner, J. A., Mason, W., Mariani, L., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043331 · Cited by 7,405 · cited 1×
“We next used established and primary GBM cell lines (Sarkaria et al., 2006) to evaluate whether the GATA4mediated sensitization was dependent on TP53 status and MGMT, the DNA repair enzyme which is most often implicated in temozolomide resistance (Hegi et al., 2004, 2005).”
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857 · cited 17×
“Promoter methylation and somatic mutations silence GATA4 expression To establish the etiology of GATA4 loss in human GBMs, we first determined whether there was epigenetic silencing by hypermethylation of the GATA4 promoter, as demonstrated in lung and colon cancer (Akiyama et al., 2003; Guo et al., 2004; Hellebrekers…”
BackgroundInfluentialNonsense-mediated mRNA decay: splicing, translation and mRNP dynamics
Maquat, L. E. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1310 · Cited by 1,214 · cited 1×
“Given the fact that these mutations occur in exons near intron/exon boundaries, it is highly suggestive that these mutant transcripts are targeted for destruction by the mRNA nonsense-mediated decay pathway (Maquat, 2004).”
BackgroundGATA4 transcription factor is required for ventral morphogenesis and heart tube formation.
Kuo, C. T., Morrisey, E. E., Anandappa, R., Sigrist, K., Lu, M. M., Parmacek, M. S., Soudais, C., & Leiden, J. M. (1997) · Genes & Development · doi:10.1101/gad.11.8.1048 · Cited by 1,037 · cited 4×
“They regulate biological functions, including organogenesis, differentiation, proliferation, and apoptosis (Kuo et al., 1997; Charron et al., 1999; Koutsourakis et al., 1999; Holtzinger and Evans, 2005; Kobayashi et al., 2006; Watt et al., 2007), but their roles in the normal and transformed human central nervous syst…”
InfluentialPollard, S. M., Yoshikawa, K., Clarke, I. D., Danovi, D., Stricker, S., Russell, R., Bayani, J., Head, R., Lee, M., Bernstein, M., et al. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.03.014 · Cited by 1,025 · cited 1×
“We screened two GBM BTIC lines generated from operative tissue as previously described (Pollard et al., 2009).”
MethodSelf-citationThe Zinc Finger-containing Transcription Factors GATA-4, -5, and -6
Molkentin, J. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.r000029200 · Cited by 880 · cited 1×
“The GATA family of transcription factors consists of six members, with two conserved zinc finger domains that recognize the consensus DNA binding motif of (A/T)/GATA/(A/G) (Molkentin, 2000).”
BackgroundHegi, M. E., Diserens, A.-C., Godard, S., Dietrich, P.-Y., Regli, L., Ostermann, S., Otten, P., Van Melle, G., de Tribolet, N., & Stupp, R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0384 · Cited by 783 · cited 1×
“We next used established and primary GBM cell lines (Sarkaria et al., 2006) to evaluate whether the GATA4mediated sensitization was dependent on TP53 status and MGMT, the DNA repair enzyme which is most often implicated in temozolomide resistance (Hegi et al., 2004, 2005).”
BiQ Analyzer: visualization and quality control for DNA methylation data from bisulfite sequencing
Bock, C., Reither, S., Mikeska, T., Paulsen, M., Walter, J., & Lengauer, T. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bti652 · Cited by 621 · cited 2×
“analyzed using BiQ analyzer software (v2.0; Bock et al., 2005).”
Cloughesy, T. F., Yoshimoto, K., Nghiemphu, P., Brown, K., Dang, J., Zhu, S., Hsueh, T., Chen, Y., Wang, W., Youngkin, D., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050008 · Cited by 593 · cited 1×
“Tissue microarray analysis of primary GBM linked with survival data (Cloughesy et al., 2008 ;Guo et al., 2009; n = 43, primary GBM) demonstrated poorer overall survival in patients with loss of GATA4 expression, compared with patients with GATA4 expression (Fig.”
Self-citationThe transcription factor GATA6 is essential for early extraembryonic development
Koutsourakis, M., Langeveld, A., Patient, R., Beddington, R., & Grosveld, F. (1999) · Development · doi:10.1242/dev.126.4.723 · Cited by 461
Denny, B. J., Wheelhouse, R. T., Stevens, M. F. G., Tsang, L. L. H., & Slack, J. A. (1994) · Biochemistry · doi:10.1021/bi00197a003 · Cited by 442 · cited 2×
“Excluding O6 guanine methylation, which is repaired by MGMT, temozolomide alkylates DNA at the N7 position of guanine and the N3 position of adenine (Denny et al., 1994), lesions which are repaired by alkylpurine-DNA-N-glycosylase (APNG; Hang et al., 1997).”
GFAP promoter elements required for region‐specific and astrocyte‐specific expression
Lee, Y., Messing, A., Su, M., & Brenner, M. (2008) · Glia · doi:10.1002/glia.20622 · Cited by 424 · cited 1×
“This is of high interest, as this region contains a highly conserved GATA element among several mammalian species (Lee et al., 2008).”
BackgroundNational survey of patterns of care for brain-tumor patients
Mahaley, M. S., Mettlin, C., Natarajan, N., Laws, E. R., & Peace, B. B. (1989) · Journal of Neurosurgery · doi:10.3171/jns.1989.71.6.0826 · Cited by 383 · cited 2×
“Vol. 208 No. 4 689-702 www.jem.org/cgi/doi/10.1084/jem.20102099 689 Malignant astrocytomas are the most common and lethal adult primary brain tumors, with Glioblastoma Multiforme (GBM) being the most aggressive astrocytoma (Mahaley et al., 1989; Kleihues and Cavanee, 2000).”
InfluentialGuo, D., Prins, R. M., Dang, J., Kuga, D., Iwanami, A., Soto, H., Lin, K. Y., Huang, T. T., Akhavan, D., Hock, M. B., et al. (2009) · Science Signaling · doi:10.1126/scisignal.2000446 · Cited by 351 · cited 1×
“Tissue microarray analysis of primary GBM linked with survival data (Cloughesy et al., 2008 ;Guo et al., 2009; n = 43, primary GBM) demonstrated poorer overall survival in patients with loss of GATA4 expression, compared with patients with GATA4 expression (Fig.”
Self-citationProliferation of human malignant astrocytomas is dependent on Ras activation
Guha, A., Feldkamp, M. M., Lau, N., Boss, G., & Pawson, A. (1997) · Oncogene · doi:10.1038/sj.onc.1201455 · Cited by 337 · cited 1×
“Cell Cycle, BrdU proliferation assays, caspase 3/7 assays, and ChIP assays were done using standard methods as previously described in detail (Guha et al., 1997; Ding et al., 2001; Shannon et al., 2005; Kamnasaran et al., 2007; Agnihotri et al., 2009).”
Self-citationGlioma Stem Cells: A Midterm Exam
Stiles, C. D., & Rowitch, D. H. (2008) · Neuron · doi:10.1016/j.neuron.2008.05.031 · Cited by 330 · cited 1×
“These BTICs are able to selfrenew, proliferate, and give rise to different lineages (Singh et al., 2004; Stiles and Rowitch, 2008).”
BackgroundSonoda, Y., Ozawa, T., Hirose, Y., Aldape, K. D., McMahon, M., Berger, M. S., & Pieper, R. O. (2001) · PubMed · Cited by 298
Self-citationDing, H., Roncari, L., Shannon, P. T., Wu, X., Lau, N. C., Karásková, J., Gutmann, D. H., Squire, J. A., Nagy, A., & Guha, A. (2001) · PubMed · Cited by 271
Self-citationSarkaria, J. N., Carlson, B. L., Schroeder, M. A., Grogan, P., Brown, P. D., Giannini, C., Ballman, K. V., Kitange, G. J., Guha, A., Pandita, A., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2510 · Cited by 270 · cited 4×
“GBM6 and GBM8 xenograft lines were established from serially passaged mice xenografts models as previously described (Sarkaria et al., 2006).”
InfluentialSelf-citationAkiyama, Y., Watkins, N., Suzuki, H., Jair, K.-W., van Engeland, M., Esteller, M., Sakai, H., Ren, C.-Y., Yuasa, Y., Herman, J. G., et al. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.23.8429-8439.2003 · Cited by 246 · cited 3×
“GATA4 is frequently silenced in lung, colon, prostate, ovarian, and breast cancer (Akiyama et al., 2003; Guo et al., 2004, 2006; Caslini et al., 2006; Hua et al., 2009), but its exact role in cancer biology and the mechanisms by which it operates are poorly understood.”
Cooperative Interaction between GATA-4 and GATA-6 Regulates Myocardial Gene Expression
Charron, F., Paradis, P., Bronchain, O., Nemer, G., & Nemer, M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.6.4355 · Cited by 243 · cited 2×
“They regulate biological functions, including organogenesis, differentiation, proliferation, and apoptosis (Kuo et al., 1997; Charron et al., 1999; Koutsourakis et al., 1999; Holtzinger and Evans, 2005; Kobayashi et al., 2006; Watt et al., 2007), but their roles in the normal and transformed human central nervous syst…”
Long-term tripotent differentiation capacity of human neural stem (NS) cells in adherent culture
Sun, Y., Pollard, S., Conti, L., Toselli, M., Biella, G., Parkin, G., Willatt, L., Falk, A., Cattaneo, E., & Smith, A. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.02.014 · Cited by 227
Gata4 regulates the formation of multiple organs
Holtzinger, A., & Evans, T. (2005) · Development · doi:10.1242/dev.01978 · Cited by 205 · cited 1×
“They regulate biological functions, including organogenesis, differentiation, proliferation, and apoptosis (Kuo et al., 1997; Charron et al., 1999; Koutsourakis et al., 1999; Holtzinger and Evans, 2005; Kobayashi et al., 2006; Watt et al., 2007), but their roles in the normal and transformed human central nervous syst…”
BackgroundDevelopment of the mammalian liver and ventral pancreas is dependent on GATA4
Watt, A. J., Zhao, R., Li, J., & Duncan, S. A. (2007) · BMC Developmental Biology · doi:10.1186/1471-213x-7-37 · Cited by 205 · cited 2×
“They regulate biological functions, including organogenesis, differentiation, proliferation, and apoptosis (Kuo et al., 1997; Charron et al., 1999; Koutsourakis et al., 1999; Holtzinger and Evans, 2005; Kobayashi et al., 2006; Watt et al., 2007), but their roles in the normal and transformed human central nervous syst…”
Hirano, S. (2012) · Methods in Molecular Biology · doi:10.1007/978-1-62703-002-1_6 · Cited by 201
GATA4 and GATA5 are Potential Tumor Suppressors and Biomarkers in Colorectal Cancer
Hellebrekers, D. M. E. I., Lentjes, M. H. F. M., van den Bosch, S. M., Melotte, V., Wouters, K. A. D., Daenen, K. L. J., Smits, K. M., Akiyama, Y., Yuasa, Y., Sanduleanu, S., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0055 · Cited by 199 · cited 3×
“Our study is the first mechanistic investigation of the tumor-suppressive actions of GATA4, whose loss has been documented in other human cancers (Cai et al., 2009; Hellebrekers et al., 2009; Hua et al., 2009).”
Pehlivan, T., Pober, B. R., Brueckner, M., Garrett, S., Slaugh, R., Van Rheeden, R., Wilson, D. B., Watson, M. S., & Hing, A. V. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990319)83:3<201::aid-ajmg11>3.0.co;2-v · Cited by 191 · cited 2×
“5) as a result of cardiac defects (Kuo et al., 1997; Pehlivan et al., 1999; Reamon-Buettner et al., 2007), and GATA4 mutations cause Holt-Oram syndrome and congenital heart defects.”
InfluentialTumour-suppressor genes: evolving definitions in the genomic age
Haber, D. A., & Harlow, E. (1997) · Nature Genetics · doi:10.1038/ng0897-320 · Cited by 141 · cited 1×
“Direct evidence comes from data presented in this manuscript where GATA4 fulfills the hallmarks of a TSG in cancer development (Haber and Harlow, 1997), specifically human astrocytomas.”
BackgroundHang, B., Singer, B., Margison, G. P., & Elder, R. H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.12869 · Cited by 140 · cited 2×
“Excluding O6 guanine methylation, which is repaired by MGMT, temozolomide alkylates DNA at the N7 position of guanine and the N3 position of adenine (Denny et al., 1994), lesions which are repaired by alkylpurine-DNA-N-glycosylase (APNG; Hang et al., 1997).”
Hypermethylation of the GATA Genes in Lung Cancer
Guo, M., Akiyama, Y., House, M. G., Hooker, C. M., Heath, E., Gabrielson, E. W., Yang, S. C., Han, Y. K., Baylin, S. B., Herman, J. G., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1140 · Cited by 130 · cited 5×
“Promoter methylation and somatic mutations silence GATA4 expression To establish the etiology of GATA4 loss in human GBMs, we first determined whether there was epigenetic silencing by hypermethylation of the GATA4 promoter, as demonstrated in lung and colon cancer (Akiyama et al., 2003; Guo et al., 2004; Hellebrekers…”
InfluentialTranscription factor GATA4 regulates cardiac BCL2 gene expression in vitro and in vivo
Kobayashi, S., Lackey, T., Huang, Y., Bisping, E., Pu, W. T., Boxer, L. M., & Liang, Q. (2006) · The FASEB Journal · doi:10.1096/fj.05-5426fje · Cited by 116 · cited 2×
“They regulate biological functions, including organogenesis, differentiation, proliferation, and apoptosis (Kuo et al., 1997; Charron et al., 1999; Koutsourakis et al., 1999; Holtzinger and Evans, 2005; Kobayashi et al., 2006; Watt et al., 2007), but their roles in the normal and transformed human central nervous syst…”
Histone modifications silence the GATA transcription factor genes in ovarian cancer
Caslini, C., Capo‐chichi, C. D., Roland, I., Nicolas, É., Yeung, A. T., & Xx, X. (2006) · Oncogene · doi:10.1038/sj.onc.1209533 · Cited by 115 · cited 1×
“GATA4 is frequently silenced in lung, colon, prostate, ovarian, and breast cancer (Akiyama et al., 2003; Guo et al., 2004, 2006; Caslini et al., 2006; Hua et al., 2009), but its exact role in cancer biology and the mechanisms by which it operates are poorly understood.”
BackgroundGATA-6 Induces p21Cip1 Expression and G1Cell Cycle Arrest
Perlman, H., Suzuki, E., Simonson, M., Smith, R. C., & Walsh, K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13713 · Cited by 114 · cited 2×
“The induction of cell cycle inhibitors and cyclins by other GATA transcription factors has been previously demonstrated by us and others (Perlman et al., 1998; Setogawa et al., 2006; Agnihotri et al., 2009); however, our observation of the induction of P21CIP1 or attenuation of CCND1 by GATA4 has…”
The transcription factor GATA6 is essential for early extraembryonic development
Koutsourakis, M., Langeveld, A., Patient, R. K., et al. (1999) · Development · doi:10.1242/dev.126.9.723 · Cited by 114
Reamon-Buettner, S. M., Cho, S.-H., & Borlak, J. (2007) · BMC Medical Genetics · doi:10.1186/1471-2350-8-38 · Cited by 102 · cited 2×
“5) as a result of cardiac defects (Kuo et al., 1997; Pehlivan et al., 1999; Reamon-Buettner et al., 2007), and GATA4 mutations cause Holt-Oram syndrome and congenital heart defects.”
InfluentialGATA6 is an astrocytoma tumor suppressor gene identified by gene trapping of mouse glioma model
Kamnasaran, D., Qian, B., Hawkins, C., Stanford, W. L., & Guha, A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611669104 · Cited by 70 · cited 5×
“Cell Cycle, BrdU proliferation assays, caspase 3/7 assays, and ChIP assays were done using standard methods as previously described in detail (Guha et al., 1997; Ding et al., 2001; Shannon et al., 2005; Kamnasaran et al., 2007; Agnihotri et al., 2009).”
InfluentialSelf-citationMacrophage Inflammatory Protein-2 and KC Induce Chemokine Production by Mouse Astrocytes
Luo, Y., Fischer, F. R., Hancock, W. W., & Dorf, M. E. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.7.4015 · Cited by 67
Hypermethylation of the GATA gene family in esophageal cancer
Guo, M., House, M. G., Akiyama, Y., Qi, Y., Capagna, D., Harmon, J. W., Baylin, S. B., Brock, M. V., & Herman, J. G. (2006) · International Journal of Cancer · doi:10.1002/ijc.22092 · Cited by 65 · cited 1×
“GATA4 is frequently silenced in lung, colon, prostate, ovarian, and breast cancer (Akiyama et al., 2003; Guo et al., 2004, 2006; Caslini et al., 2006; Hua et al., 2009), but its exact role in cancer biology and the mechanisms by which it operates are poorly understood.”
Agnihotri, S., Wolf, A., Picard, D. J., Hawkins, C. E., & Guha, A. (2009) · Oncogene · doi:10.1038/onc.2009.159 · Cited by 61 · cited 7×
“…cell cycle inhibitors and cyclins by other GATA transcription factors has been previously demonstrated by us and others (Perlman et al., 1998; Setogawa et al., 2006; Agnihotri et al., 2009); however, our observation of the induction of P21CIP1 or attenuation of CCND1 by GATA4 has not been reported.”
InfluentialSelf-citationCai, K. Q., Caslini, C., Capo‐chichi, C. D., Slater, C. M., Smith, E. R., Wu, H. G., Klein–Szanto, A. J., Godwin, A. K., & Xu, X. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006454 · Cited by 61 · cited 1×
“Our study is the first mechanistic investigation of the tumor-suppressive actions of GATA4, whose loss has been documented in other human cancers (Cai et al., 2009; Hellebrekers et al., 2009; Hua et al., 2009).”
BackgroundPathological and Molecular Progression of Astrocytomas in a GFAP:12V-Ha-Ras Mouse Astrocytoma Model
Shannon, P. T., Sabha, N., Lau, N. C., Kamnasaran, D., Gutmann, D. H., & Guha, A. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62057-3 · Cited by 57
Self-citationRestrepo, A., Smith, C. A., Agnihotri, S., Shekarforoush, M., Kongkham, P. N., Seol, H. J., Northcott, P. A., & Rutka, J. T. (2010) · Neuro-Oncology · doi:10.1093/neuonc/noq145 · Cited by 57 · cited 1×
“Although this may imply GFAP regulation by GATA4, the co-loss may also arise as a result of the fact that GATA4 and GFAP are both targeted for epigenetic silencing (Restrepo et al., 2011; this paper).”
Self-citationThe tumor suppressor LKB1 induces p21 expression in collaboration with LMO4, GATA-6, and Ldb1
Setogawa, T., Shinozaki-Yabana, S., Masuda, T., Matsuura, K., & Akiyama, T. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.03.077 · Cited by 45 · cited 2×
“The induction of cell cycle inhibitors and cyclins by other GATA transcription factors has been previously demonstrated by us and others (Perlman et al., 1998; Setogawa et al., 2006; Agnihotri et al., 2009); however, our observation of the induction of P21CIP1 or attenuation of CCND1 by GATA4 has not been reported.”
Hua, G., Zhu, B., Rosa, F., Deblon, N., Adélaïde, J., Kahn‐Perlès, B., Birnbaum, D., & Imbert, J. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0175 · Cited by 42 · cited 2×
“Our study is the first mechanistic investigation of the tumor-suppressive actions of GATA4, whose loss has been documented in other human cancers (Cai et al., 2009; Hellebrekers et al., 2009; Hua et al., 2009).”
BackgroundSignaling in Malignant Astrocytomas: Role of Neural Stem Cells and Its Therapeutic Implications
Llaguno, S. R. A., Chen, J., & Parada, L. F. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0433 · Cited by 40 · cited 1×
“We investigated the status of GATA4 in GBM brain tumor initiation cells (BTICs), which are postulated to be responsible for tumor initiation and maintenance and resistance to therapy (Alcantara Llaguno et al., 2009).”
Expression of GATA6 in the human and mouse central nervous system
Kamnasaran, D., & Guha, A. (2005) · Developmental Brain Research · doi:10.1016/j.devbrainres.2005.07.012 · Cited by 29 · cited 7×
“We have previously reported on the expression profile of GATA6 in the CNS (Kamnasaran and Guha, 2005) and recently reported GATA4 expression in normal embryonic and adult mouse and human astrocytes, in which it functions as an inhibitor of proliferation and inducer of apoptosis (Agnihotri et al.”
InfluentialSelf-citation
Research works printed but not linked: 1
- Kleihues, 2000, World Health Organization Classification of Tumors: Pathology and Genetic: Tumors of the Nervous System
Cited by
The DNA damage response induces inflammation and senescence by inhibiting autophagy of GATA4.
Kang, C., Xu, Q., Martin, T. D., Li, M. Z., Demaria, M., Aron, L., Lu, T., Yankner, B. A., Campisi, J., & Elledge, S. J. (2015) · Science · doi:10.1126/science.aaa5612 · Cited by 982
“Consistent with a regulatory role in senescence, GATA4 is frequently silenced in lung, colon, prostate, ovarian, and breast cancer (38, 39).”
BackgroundEpidemiology of Glioblastoma Multiforme–Literature Review
Grochans, S., Cybulska, A. M., Simińska, D., Korbecki, J., Kojder, K., Chlubek, D., & Baranowska-Bosiacka, I. (2022) · Cancers · doi:10.3390/cancers14102412 · Cited by 630
“[63] showed that: (i) in 94/163 human GBM tumor cells, GATA4 expression was lost, (ii) GATA4 inhibited transformation to GBM in vitro and in vivo, and (iii) the re-expression of GATA4 in GBM cells sensitized them to telosomide, regardless of the MGMT mutation status.”
Agnihotri, S., Burrell, K. E., Wolf, A., Jalali, S., Hawkins, C., Rutka, J. T., & Zadeh, G. (2013) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-012-0203-0 · Cited by 272
Self-citationThe emerging role of GATA transcription factors in development and disease
Lentjes, M. H., Niessen, H. E., Akiyama, Y., de Bruïne, A. P., Melotte, V., & van Engeland, M. (2016) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2016.2 · Cited by 249
“136).”
InfluentialPersonalized treatment strategies in glioblastoma: MGMT promoter methylation status
Thon, N., Kreth, S., & Kreth, F. W. (2013) · OncoTargets and Therapy · doi:10.2147/ott.s50208 · Cited by 166
Metadata
- Authors
- Agnihotri, S., Wolf, A., Munoz, D. M., Smith, C. J., Gajadhar, A., Restrepo, A., Clarke, I. D., Fuller, G. N., Kesari, S., Dirks, P. B., McGlade, C. J., Stanford, W. L., Aldape, K., Mischel, P. S., Hawkins, C., & Guha, A.
- Affiliations
- University of Toronto (CA)
- The Arthur and Sonia Labatt’s Brain Tumor Research Centre, The Hospital for Sick Children’s Research Institute 1 , 2 , 3 , and 4
- The University of Texas MD Anderson Cancer Center (US)
- University of California San Diego (US)
- University of California, Los Angeles (US)
- Corresponding author
- Guha, Abhijit
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2011-04-04
- Volume
- 208
- Issue
- 4
- Pages
- 689-702
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC3135351
- OpenAlex
- W2167377849
- Cited by
- 92
- References
- 53
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 1 · 2023: 4 · 2022: 10 · 2021: 3 · 2020: 5 · 2019: 5 · 2018: 5 · 2017: 6 · 2016: 8 · 2015: 6 · 2014: 2 · 2013: 10 · 2012: 9
- FWCI
- 4.38
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › FOXO transcription factor regulation
- Keywords
- GATA4, glioblastoma, astrocytoma, tumor suppressor, transcription factors, promoter hypermethylation, Ras activation, p53 deficiency, p21 Cip1, temozolomide sensitivity, MGMT, DNA repair, cancer stem cells, neurospheres, cell cycle inhibition, prognostic factors
- MeSH terms
- Temozolomide, Animals, Brain Neoplasms, Dacarbazine, Glioblastoma, Humans, Promoter Regions, Genetic, DNA Modification Methylases, DNA Methylation, Cyclin D1, Tumor Suppressor Proteins, DNA Repair Enzymes, Cell Line, Tumor, Cell Proliferation, Cyclin-Dependent Kinase Inhibitor p21, GATA4 Transcription Factor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.